-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Lineage Cell Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $94K.
- Lineage Cell Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.39M, a 566% increase year-over-year.
- Lineage Cell Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $1.45M.
- Lineage Cell Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.29M, a 155% decline from 2021.
- Lineage Cell Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5.94M, a 31.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)